Patents by Inventor Dasha Cabel

Dasha Cabel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of the chemokine receptor CxCR3
    Patent number: 8268828
    Abstract: This invention is directed to a 3-(amido or sulphamido)-4-(4-substituted-azinyl)benzamide or benzsulphonamide compound as defined herein. The 3-(amido or sulphamido)-(4-substituted-azinyl)benzamide or benzsulphonamide compound is useful as a inhibitor of the chemokine receptor CxCR3, and for preventing or treating a CxCR3 chemokine receptor mediated disease or condition related thereto in a patient in need of such.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: September 18, 2012
    Assignee: Sanofi
    Inventors: David Squire Thorpe, Martin Smrcina, Dagmar Dasha Cabel
  • SRC kinase inhibitors useful for treating osteoporosis
    Publication number: 20040014676
    Abstract: Amide containing aromatic compounds having an inhibitory effect on Src kinase including enantiomers, stereoisomers and tautomers thereof, as well as pharmaceutically acceptable salts or solvates of said compound, said compound having the general structure shown in Formulae I through XVIII.
    Type: Application
    Filed: July 9, 2002
    Publication date: January 22, 2004
    Inventors: Ramalinga Dharanipragada, Fahad Al-Obeidi, Gary Flynn, Dasha Cabel